$0.194
+0.007 (+3.41%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CNTX por análisis de gráficos similares
Alphio's CNTX stock price prediction model matches the current Context Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.20 (+1.63%). The 1-week path is $0.20 (+4.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Context Therapeutics Inc?
Context Therapeutics Inc (CNTX) is not a good buy right now due to significant financial losses and a low RSI of 34.848, indicating potential further declines. The stock has a current price of $0.19, which is only 0.4% of its 52-week high of $3.62, suggesting it is trading at a very low valuation. The main risk is the widening net loss, which reached $14.56 million in Q2 2026, raising concerns about sustainability.
CNTX cerró en $0.19 el Friday, tras subir +3.41%
Context Therapeutics Inc (CNTX) last closed at $0.1943, gaining +3.41%. These facts feed the 1-day and 1-week CNTX price prediction above.
Factores de la previsión
Los factores de la previsión de Context Therapeutics Inc (CNTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CNTX, ordenadas por similitud.
Análisis de estacionalidad de CNTX
Historically the probability of a positive November return for CNTX is 47.73%. May offers the highest probability of a positive month at 66.67%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CNTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.89 | $1.01 | $1.14 | +421.31% |
| Dec 2026 | $0.79 | $0.89 | $0.98 | +357.42% |
En 2026, se proyecta que Context Therapeutics Inc (CNTX) oscile entre $0.79 y $1.14.
Previsión mensual de Context Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Context Therapeutics Inc promedie $1.01, con un mínimo de $0.89 y un máximo de $1.14.
En Dec de 2026, se proyecta que Context Therapeutics Inc promedie $0.89, con un mínimo de $0.79 y un máximo de $0.98.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.